GENE ONLINE|News &
Opinion
Blog

Series C Funding
Forge Biologics Raises $90 Million To Expand Gene Therapy CDMO
2022-09-14
Kriya Bags $270 Million Series C to Support Integrated Gene Therapies
2022-05-18
Mental Healthcare Startup Cerebral Valued at $4.8 Billion after $300 Million Softbank-led Series C
2021-12-10
China’s Neurophth Snags $63 Million in Series C to Boost Ophthalmic Gene Therapy Portfolio
2021-11-25
Taiwan’s Acepodia Closes $100 Million Series C to Accelerate Cancer Assets
2021-11-22
South Korea’s D&D Pharmatech Secures $51M Series C, Eyes 2022 IPO
2021-10-20
Allay Therapeutics Raises $60 Million to Finance its Non-Opioid Pain Management Platform
2021-09-16
Japanese Biotech Raises $37 Million in Series C to Develop Stem Cell Therapy for Heart Failure
2021-06-13
Oculis Raises $50 Million to Push Ophthalmic Portfolio and Expand International Foothold
2021-05-06
Arch Oncology Secures $105 Million in Funding for Advancing Anti-CD47 Therapy
2021-04-29
Monte Rosa Bags $95 Million Series C Funding to Advance Protein Degraders
2021-03-14
Massachusetts Cancer Startup to Fund Mission of Drugging the Undruggable with $107M Series C Round
2021-03-07
Tenaya Raises $106 Million Series C Round To Fight Heart Disease
2021-03-04
Clover Biopharmaceuticals Raises $230 Million to Expand Trimer-Tag Technology
2021-02-28
AI Powered Startup XtalPi Announces 300 Million Series C Funding
2020-09-30
1 2
LATEST
OncoC4 Bags $200 Million In CTLA-4 Antibody Pact With BioNTech
2023-03-21
HHS Issues Initial Guidance on Negotiation Program as Government’s Latest Move to Reduce Drug Prices
2023-03-21
First-Ever Insect Brain Neuron Map Completed
2023-03-21
AbbVie Unveils Latest Data For Skyrizi In Difficult-To-Treat Psoriasis
2023-03-20
Sanofi Slashes Insulin Prices by Up to 78% Following Hot On the Heels of Major Competitors
2023-03-19
Novartis Snags Pediatric Brain Cancer Indication for Oncology Combination Therapy
2023-03-19
Pfizer, Astellas’ Prostate Cancer Drug Xtandi Achieves Goals In Phase 3
2023-03-19
Scroll to Top